COMPASS Knowledge Navigator
We are transforming the patient experience in mental health care. We think differently about mental health and are acting urgently to deliver innovation that will enable people to live happier and healthier lives.
Click below to find out more
The mental health crisis
We are leaders in innovation
Latest results
There are too many people who are suffering with mental health challenges like depression, and who aren’t helped by existing therapies.
Click below to find out more
COMP360 psilocybin therapy has the potential to help those who are suffering and don't have many options.
Click below to find out more
Largest randomised, controlled, double-blind psilocybin therapy study ever completed shows rapid and sustained response for patients receiving a single dose of COMP360 psilocybin with psychological support
Click below to find out more
Primary endpoint – change from baseline in MADRS total score
Key secondary endpoint - MADRS responders
Key secondary endpoint - MADRS remitters
Safety – treatment emergent adverse events (TEAEs) overview
Study design and endpoints
MADRS sustained responders at week 12
Complete results
